DGFT restricts the export of Hydroxychoroquine and formulations made from Hydroxychloroquine

Mar 31, 2020 | by Avantis RegTech Legal Research Team


Finance & Taxation Compliance

The Directorate General of Foreign Trade (DGFT) on March 25, 2020, prohibits export of Hydroxychoroquine and formulations made from Hydroxychloroquine with immediate effect.

However, the export of Hydroxychoroquine and formulations made it shall be allowed under following conditions:

A. Export will be allowed from the Special Economic Zone (SEZ) or Export Oriented Units (EOU) Units and in cases where export is made to fulfill export obligation under any Advance license issued on or before the date of this Notification.

B. Export will be allowed in case of shipments where irrevocable letter of credit (ICLC) has been issued before the date of this Notification or in case where full advance payment has been received by the exporter in India against specific shipment, subject to submission of documentary evidence.

C. Exports will also be allowed by the Government of India to other countries on humanitarian grounds on case to case basis on the recommendation of Ministry of External Affairs.

[Notification No. 54/2015-2020] 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.